| Unique ID issued by UMIN | UMIN000063517 |
|---|---|
| Receipt number | R000072529 |
| Scientific Title | Scheduled intraoperative repeated skin lavage with dilute povidone-iodine for suppression of Cutibacterium acnes re-emergence during arthroscopic shoulder surgery: a randomized controlled trial, with a nested serum testosterone substudy. RIPPLE study (Repeated Intraoperative Povidone-Iodine Protocol for Lavage Efficacy) |
| Date of disclosure of the study information | 2026/11/17 |
| Last modified on | 2026/11/12 21:30:29 |
Repeated skin lavage with dilute povidone-iodine during arthroscopic shoulder surgery to prevent Cutibacterium acnes re-emergence, with a serum testosterone substudy
RIPPLE study
Scheduled intraoperative repeated skin lavage with dilute povidone-iodine for suppression of Cutibacterium acnes re-emergence during arthroscopic shoulder surgery: a randomized controlled trial, with a nested serum testosterone substudy. RIPPLE study (Repeated Intraoperative Povidone-Iodine Protocol for Lavage Efficacy)
RIPPLE study
| Japan |
Patients undergoing arthroscopic rotator cuff repair or arthroscopic Bankart repair (rotator cuff tear, anterior shoulder instability)
| Orthopedics |
Others
NO
To determine whether repeated intraoperative skin lavage with 0.35% dilute povidone-iodine at 30-minute intervals after standard surgical skin preparation reduces Cutibacterium acnes (C. acnes) culture positivity immediately before wound closure during arthroscopic shoulder surgery. This randomized controlled trial also includes two nested substudies: evaluation of C. acnes re-emergence approximately 60 minutes after skin preparation and investigation of the association between preoperative serum total testosterone levels and shoulder skin C. acnes burden, primarily in male patients.
Efficacy
Confirmatory
Explanatory
Not applicable
Cutibacterium acnes culture positivity rate in shoulder skin swab samples collected immediately before wound closure (before initiation of suturing, Tclosure), compared between the control group and the repeated 0.35% dilute povidone-iodine lavage group.
1. C. acnes culture positivity rates before skin preparation (T0) and immediately after skin preparation (T1).
2. C. acnes culture conversion from negative at T1 to positive immediately before wound closure (Tclosure).
3. Semiquantitative C. acnes burden (negative, 1+, 2+, 3+) at T0, T1, approximately 60 minutes after skin preparation (T60), and Tclosure, including changes over time.
4. Association between the time interval (minutes) from completion of the last lavage to culture sampling at Tclosure and C. acnes positivity in the lavage group. In the control group, the interval from completion of skin preparation to Tclosure will be evaluated.
5. Comparison of C. acnes culture positivity rates and semiquantitative bacterial burden at T60 (immediately before the second lavage in the intervention group) between groups.
6. Association between preoperative serum total testosterone levels and baseline (T0) semiquantitative C. acnes burden in male patients.
7. Exploratory associations of serum total testosterone levels with C. acnes burden and culture positivity at T60 and Tclosure, effect modification of repeated lavage, sex-related differences, and prediction of C. acnes culture positivity at wound closure.
8. Postoperative wound complications within 30 days after surgery.
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
No treatment
YES
NO
Institution is not considered as adjustment factor.
YES
Central registration
2
Prevention
| Medicine |
Control group (Group A): Standard surgical skin preparation with alcohol-based 10% povidone-iodine (PVP-I-ALC) is performed during arthroscopic shoulder surgery. No additional intraoperative skin lavage is performed. The intervention period is limited to a single surgical procedure. Skin swab samples for C. acnes culture are collected before skin preparation (T0), immediately after skin preparation (T1), approximately 60 minutes after skin preparation (T60, if eligible), and immediately before wound closure (Tclosure).
Repeated lavage group (Group B): Following standard surgical skin preparation with alcohol-based 10% povidone-iodine (PVP-I-ALC), repeated intraoperative skin lavage with 0.35% dilute povidone-iodine is performed. The first lavage is performed 30 minutes after completion of skin preparation, followed by repeated lavage every 30 minutes after completion of the preceding lavage. Approximately 200 mL of 0.35% dilute povidone-iodine is applied to the entire shoulder skin surface using a 50-mL irrigation syringe four times over approximately 15 seconds per lavage, without wiping. Lavage is repeated until suturing begins. The intervention period is limited to a single surgical procedure. Skin swab samples for C. acnes culture are collected before skin preparation (T0), immediately after skin preparation (T1), immediately before the second lavage (T60, if eligible), and immediately before wound closure (Tclosure).
| Not applicable |
| Not applicable |
Male and Female
1. Patients scheduled to undergo elective primary arthroscopic rotator cuff repair (ARCR) or arthroscopic Bankart repair (ABR).
2. No restrictions on age or sex.
3. Patients who have not declined participation in the study.
1. Active infection of the operative shoulder, surgery for infection, or a history of previous surgery on the ipsilateral shoulder.
2. Active skin disease or skin damage at the operative site.
3. Known hypersensitivity to povidone-iodine (iodine) or alcohol.
4. Systemic antibiotic treatment within 2 weeks before surgery, excluding perioperative prophylactic antibiotics.
5. Preoperative skin decolonization treatment targeting C. acnes, including topical benzoyl peroxide (BPO).
6. Any other condition considered unsuitable for participation by the principal investigator.
200
| 1st name | Hideki |
| Middle name | |
| Last name | Kamijo |
Funabashi Orthopaedic Hospital
Shoulder & Elbow Service, Sports Medicine & Joint Center
274-0822
1-845 Hasama Funabashi, Chiba
09034381126
hkamijyo@fff.or.jp
| 1st name | Hideki |
| Middle name | |
| Last name | Kamijo |
Funabashi Orthopaedic Hospital
Sports Medicine & Joint Center
274-0822
1-845 Hasama Funabashi, Chiba
047-425-5585
hideki_kamijou@yahoo.co.jp
Funabashi Orthopaedic Hospital
Funabashi Orthopaedic Hospital
Other
Funabashi Orthopaedic Hospital
1-845 Hasama Funabashi, Chiba
047-425-5585
rinri@fff.or.jp
NO
船橋整形外科病院(千葉県)
| 2026 | Year | 11 | Month | 17 | Day |
Unpublished
Preinitiation
| 2026 | Year | 11 | Month | 01 | Day |
| 2026 | Year | 10 | Month | 31 | Day |
| 2026 | Year | 12 | Month | 01 | Day |
| 2027 | Year | 06 | Month | 30 | Day |
| 2027 | Year | 07 | Month | 15 | Day |
| 2027 | Year | 07 | Month | 31 | Day |
| 2027 | Year | 08 | Month | 31 | Day |
| 2026 | Year | 11 | Month | 04 | Day |
| 2026 | Year | 11 | Month | 12 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072529